Fiduciary Trust CO Editas Medicine, Inc. Transaction History

Fiduciary Trust CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 04, 2020	SELL	$19.49 - $32.63 $703,296 - $1.18 Million	-36,085 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$22.49 - $26.81 $134 - $160	6 Added 0.02%	36,085 $821,000
Q2 2019 Aug 14, 2019	SELL	$20.48 - $27.76 $20,480 - $27,760	-1,000 Reduced 2.7%	36,079 $892,000
Q1 2019 May 07, 2019	SELL	$19.43 - $26.41 $777,200 - $1.06 Million	-40,000 Reduced 51.89%	37,079 $907,000
Q2 2018 Aug 03, 2018	BUY	$31.4 - $41.01 $2.42 Million - $3.16 Million	77,079 New	77,079 $2.76 Million

248

57M

410K

394K

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $90M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

Get notified when there are updates to the investment portfolio of Fiduciary Trust CO, based on Form 13F filings with the SEC.

Stay updated on Fiduciary Trust CO with notifications on news.